Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion evidence source_evidence_literature NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion SIO_000772 16624621 NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion wasDerivedFrom befree-20150227 NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion wasGeneratedBy ECO_0000203 NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.